Huron Consulting Group announced that it received the 9th Annual M&A Advisor Turnaround Award for work with Nephron Pharmaceuticals.

“Huron is honored to receive this prestigious award for our work with Nephron Pharmaceuticals,” said Geoffrey Frankel, managing director, Huron Transaction Advisory. “Huron’s investment banking team worked seamlessly with our financial consulting and life sciences colleagues to provide a complete solution that helped the client achieve their financing goal.”

Nephron Pharmaceuticals Corporation, a leading manufacturer of nebulized pharmaceutical products used to treat chronic respiratory conditions, engaged Huron to help reposition its operating and financial story to lenders. Within a relatively short period of time, the Company received multiple refinancing proposals resulting in the successful closing of a $205 million senior credit facility and $75 million of mezzanine notes.

Huron Consulting Group helps clients in diverse industries improve performance, transform the enterprise, reduce costs, leverage technology, process and review large amounts of complex data, address regulatory changes, recover from distress and stimulate growth.